Effect of Long-term Inhaled Corticosteroids Therapy on Cognitive Function in Patients with Bronchial Asthma and Chronic Obstructive Pulmonary Disease

Overview

Journal Lung India

Specialty Pulmonary Medicine

Date 2024 Aug 31

PMID 39215978

Authors

Suikriti Sharma

Deepika Karki

Kanivi Julitta

Affiliations

Soon will be listed here.

Abstract

Background: Inhaled corticosteroids (ICS) are prominent therapies for managing both asthma and chronic obstructive pulmonary disease (COPD). It has been noted that cognitive impairment is usually linked to high levels of corticosteroids in the blood.

Objective: This investigation aims to ascertain how long-term inhaled corticosteroid treatment affects individuals with bronchial asthma and COPD's cognitive performance.

Methodology: A total of 139 inpatients diagnosed with COPD and bronchial asthma were enrolled in the study of which 43 were newly diagnosed (group 1), 34 were taking ICS for 0.5-1 year (group 2) and 62 were on long-term ICS, that is, for >2 years (group 3). Patients with a score of at least 24 were considered to have normal cognitive function as prescribed by the Montreal Cognitive Assessment scale.

Result: It was observed that 56 patients (90.3%) were on long-term ICS treatment, 25 patients (73.5%) were on intermediate therapy and 27 patients (62.7%) who were newly diagnosed had cognitive impairment.

Conclusion: In conclusion, the duration of ICS therapy was significantly associated with a decline in cognitive function.

References

Suissa S, Barnes P . Inhaled corticosteroids in COPD: the case against. Eur Respir J. 2009; 34(1):13-6. DOI: 10.1183/09031936.00190908. View

Copersino M, Fals-Stewart W, Fitzmaurice G, Schretlen D, Sokoloff J, Weiss R . Rapid cognitive screening of patients with substance use disorders. Exp Clin Psychopharmacol. 2009; 17(5):337-44. PMC: 3144764. DOI: 10.1037/a0017260. View

Otte C, Hart S, Neylan T, Marmar C, Yaffe K, Mohr D . A meta-analysis of cortisol response to challenge in human aging: importance of gender. Psychoneuroendocrinology. 2004; 30(1):80-91. DOI: 10.1016/j.psyneuen.2004.06.002. View

Barnes P . Inhaled corticosteroids in COPD: a controversy. Respiration. 2010; 80(2):89-95. DOI: 10.1159/000315416. View

Judd L, Schettler P, Brown E, Wolkowitz O, Sternberg E, Bender B . Adverse consequences of glucocorticoid medication: psychological, cognitive, and behavioral effects. Am J Psychiatry. 2014; 171(10):1045-51. DOI: 10.1176/appi.ajp.2014.13091264. View

Birnie M, Claydon M, Troy O, Flynn B, Yoshimura M, Kershaw Y . Circadian regulation of hippocampal function is disrupted with corticosteroid treatment. Proc Natl Acad Sci U S A. 2023; 120(15):e2211996120. PMC: 10104554. DOI: 10.1073/pnas.2211996120. View

Dodd J, Getov S, Jones P . Cognitive function in COPD. Eur Respir J. 2010; 35(4):913-22. DOI: 10.1183/09031936.00125109. View

Nasreddine Z, Phillips N, Bedirian V, Charbonneau S, Whitehead V, Collin I . The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005; 53(4):695-9. DOI: 10.1111/j.1532-5415.2005.53221.x. View

Lupien S, Maheu F, Tu M, Fiocco A, Schramek T . The effects of stress and stress hormones on human cognition: Implications for the field of brain and cognition. Brain Cogn. 2007; 65(3):209-37. DOI: 10.1016/j.bandc.2007.02.007. View

10.

Belanoff J, Gross K, YAGER A, Schatzberg A . Corticosteroids and cognition. J Psychiatr Res. 2001; 35(3):127-45. DOI: 10.1016/s0022-3956(01)00018-8. View

11.

Arya V, Issar M, Wang Y, Talton J, Hochhaus G . Brain permeability of inhaled corticosteroids. J Pharm Pharmacol. 2005; 57(9):1159-67. DOI: 10.1211/jpp.57.9.0010. View

12.

Ancelin M, Carriere I, Helmer C, Rouaud O, Pasquier F, Berr C . Steroid and nonsteroidal anti-inflammatory drugs, cognitive decline, and dementia. Neurobiol Aging. 2011; 33(9):2082-90. DOI: 10.1016/j.neurobiolaging.2011.09.038. View

13.

Sisson J . Alcohol and airways function in health and disease. Alcohol. 2007; 41(5):293-307. PMC: 2081157. DOI: 10.1016/j.alcohol.2007.06.003. View

14.

Savas M, Vinkers C, Rosmalen J, Hartman C, Wester V, van den Akker E . Systemic and Local Corticosteroid Use Is Associated with Reduced Executive Cognition, and Mood and Anxiety Disorders. Neuroendocrinology. 2019; 110(3-4):282-291. PMC: 7114901. DOI: 10.1159/000501617. View

15.

Kendzerska T, Aaron S, To T, Licskai C, Stanbrook M, Vozoris N . Effectiveness and Safety of Inhaled Corticosteroids in Older Individuals with Chronic Obstructive Pulmonary Disease and/or Asthma. A Population Study. Ann Am Thorac Soc. 2019; 16(10):1252-1262. DOI: 10.1513/AnnalsATS.201902-126OC. View

16.

Rhyou H, Nam Y . Association between cognitive function and asthma in adults. Ann Allergy Asthma Immunol. 2020; 126(1):69-74. DOI: 10.1016/j.anai.2020.08.022. View

17.

Conrad C, Bimonte-Nelson H . Impact of the hypothalamic-pituitary-adrenal/gonadal axes on trajectory of age-related cognitive decline. Prog Brain Res. 2010; 182:31-76. DOI: 10.1016/S0079-6123(10)82002-3. View